Darmon M, Vincent F, Camous L, Canet E, Bonmati C, Braun T, et al. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique. Br J Haematol. 2013;162:489–97.
Article
CAS
Google Scholar
Howard SC, Jones DP, Pui C-H. The tumor lysis syndrome. N Engl J Med. 2011;364:1844–54.
Article
CAS
Google Scholar
Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127:3–11.
Article
Google Scholar
Cairo MS, Coiffier B, Reiter A, Younes A. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol. 2010;149:578–86.
Article
CAS
Google Scholar
Darmon M, Guichard I, Vincent F, Schlemmer B, Azoulay E. Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leuk Lymphoma. 2010;51:221–7.
Article
Google Scholar
Soares M, Salluh JIF, Carvalho MS, Darmon M, Rocco JR, Spector N. Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24:4003–10.
Article
Google Scholar
Canet E, Zafrani L, Lambert J, Thieblemont C, Galicier L, Schnell D, et al. Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS ONE. 2013;8:e55870.
Article
CAS
Google Scholar
Mantadakis E, Aquino VM, Strand WR, Quigley R. Acute renal failure due to obstruction in Burkitt lymphoma. Pediatr Nephrol. 1999;13:237–40.
Article
CAS
Google Scholar
L’Imperio V, Rossi M, Abdul A, Mehta SR, Shaver AC, Fogo AB. Lymphoma and the kidney: a kidney biopsy teaching case. Kidney Med. 2020;2:663–6.
Article
Google Scholar
Soares M, Feres GA, Salluh JIF. Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome. Clinics. 2009;64:479–81.
Article
Google Scholar
Jones GL, Will A, Jackson GH, Webb NJA, Rule S. Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2015;169:661–71.
Article
Google Scholar
Cammalleri L, Malaguarnera M. Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int J Med Sci. 2007;4:83–93.
Article
CAS
Google Scholar
Thiéry G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, Lévy V, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23:4406–13.
Article
Google Scholar
Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–74.
Article
Google Scholar
Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113:1875–91.
Article
CAS
Google Scholar
Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, et al. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol. 2017;28:1436–47.
Article
CAS
Google Scholar
Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron. 2012;120:c179–84.
Article
Google Scholar
Matheny ME, Peterson JF, Eden SK, Hung AM, Speroff T, Abdel-Kader K, et al. Laboratory test surveillance following acute kidney injury. PLoS ONE. 2014;9:e103746.
Article
Google Scholar
Lafrance J-P, Miller DR. Defining acute kidney injury in database studies: the effects of varying the baseline kidney function assessment period and considering CKD status. Am J Kidney Dis. 2010;56:651–60.
Article
Google Scholar
Siew ED, Ikizler TA, Matheny ME, Shi Y, Schildcrout JS, Danciu I, et al. Estimating baseline kidney function in hospitalized patients with impaired kidney function. Clin J Am Soc Nephrol. 2012;7:712–9.
Article
Google Scholar
Cooper DJ, Plewes K, Grigg MJ, Patel A, Rajahram GS, William T, et al. An evaluation of commonly used surrogate baseline creatinine values to classify AKI during acute infection. Kidney Int Rep. 2021;6:645–56.
Article
Google Scholar
Ferreira FL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286:1754.
Article
CAS
Google Scholar
Jones GL, Will A, Jackson GH, Webb NJA, Rule S, the British Committee for Standards in Haematology. Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2015;169:661–71.
Thomas LE, Li F, Pencina MJ. Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial. JAMA. 2020;323:2417.
Article
Google Scholar
Li F, Thomas LE, Li F. Addressing extreme propensity scores via the overlap weights. Am J Epidemiol. 2019;188:250–7.
Article
Google Scholar
Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, et al. Association of use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1020.
Article
Google Scholar
Austin PC, Steyerberg EW. Bootstrap confidence intervals for loess-based calibration curves. Stat Med. 2014;33:2699–700.
Article
Google Scholar
Spina M, Nagy Z, Ribera JM, Federico M, Aurer I, Jordan K, et al. FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. Ann Oncol Elsevier. 2015;26:2155–61.
Article
CAS
Google Scholar
Personett HA, Barreto EF, McCullough KB, Dierkhising R, Leung N, Habermann TM. Impact of early rasburicase on incidence of clinical tumor lysis syndrome in lymphoma. Leuk Lymphoma. 2019;60:2271–7.
Article
Google Scholar
Lengliné E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N, et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma. 2012;53:1352–9.
Article
Google Scholar
Canet E, Cheminant M, Zafrani L, Thieblemont C, Galicier L, Lengline E, et al. Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome? Leuk Lymphoma. 2014;55:2362–7.
Article
CAS
Google Scholar
Cheuk DKL, Chiang AKS, Chan GCF, Ha SY. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer. Cochrane Database Syst Rev. 2014;1:CD006945.
Google Scholar
Boles JM, Dutel JL, Briere J, Mialon P, Robasckiewicz M, Garre M, et al. Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia. Cancer. 1984;53:2425–9.
Article
CAS
Google Scholar
Kanfer A, Richet G, Roland J, Chatelet F. Extreme hyperphosphataemia causing acute anuric nephrocalcinosis in lymphosarcoma. Br Med J. 1979;1:1320–1.
Article
CAS
Google Scholar
Ejaz AA, Johnson RJ, Shimada M, Mohandas R, Alquadan KF, Beaver TM, et al. The role of uric acid in acute kidney injury. Nephron Karger Publishers. 2019;142:275–83.
Article
CAS
Google Scholar
Shimada M, Johnson RJ, May WS, Lingegowda V, Sood P, Nakagawa T, et al. A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome. Nephrol Dial Transplant. 2009;24:2960–4.
Article
CAS
Google Scholar
Pui C-H, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol. 2001;19:697–704.
Article
CAS
Google Scholar
Tosi P, Barosi G, Lazzaro C, Liso V, Marchetti M, Morra E, et al. Consensus conference on the management of tumor lysis syndrome. Haematologica. 2008;93:1877–85.
Article
Google Scholar
Will A, Tholouli E. The clinical management of tumour lysis syndrome in haematological malignancies. Br J Haematol. 2011;154:3–13.
Article
CAS
Google Scholar